Skip to main content
Clinical Trials/CTRI/2020/07/026757
CTRI/2020/07/026757
Not yet recruiting
Phase 3

A prospective double blind randomised controlled trial of Eupatorium perfoliatum 30 C in asymptomatic and mild symptomatic cases of COVID-19.

Ministry of AYUSH0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Ministry of AYUSH
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects testing positive for SARS CoV\-2 by RT\-PCR, presenting with no symptoms or mild symptoms.
  • 2\. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.

Exclusion Criteria

  • 1\. Cases of COVID\-19 with clinical severity ranging from moderate to critical.
  • 2\. Pregnant and lactating females.
  • 3\. Subjects having uncontrolled and unstable co morbidity.
  • 4\. Immunocompromised subjects or those taking any kind of immunosupressive therapy.
  • 5\. COVIC\-19 positive cases participating as subjects in other COVID\-19 clinical trails.
  • 6\. Subjects having past history of allergy to any medicine that is part of the Homoeopathic intervention. Other conditions, which in the opinion of the investigator, makes the patient unsuitable for enrollment or could interfere with his participation in, and completion of the protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials